Enhancing Health Literacy Through AI-Powered Chatbot

Launched by NAGASAKI UNIVERSITY · Dec 4, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring whether a digital tool, called an AI-powered chatbot, can help improve understanding about the HPV vaccination among female caregivers in Japan. The goal is to see if using this chatbot or a printed leaflet can better inform caregivers about HPV, which is important for protecting their daughters from certain cancers.

To participate, caregivers should have daughters aged 12-18 who have not yet received the HPV vaccine and must have access to a smartphone or computer with internet. Participants will begin by answering a survey about their current knowledge, then they will receive information through the chatbot or leaflet for two weeks, followed by another survey to see if their understanding has improved. Please note that this study is not yet recruiting participants, and those who have difficulty accessing the online materials or need help with reading will not be eligible.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • A nationally representative sample of female caregivers with daughters aged 12-18 who have not received any HPV vaccine.
• • Those who have access to a smartphone or computer with internet connectivity to interact with experiment materials (chatbot or online leaflet).
• • Those who provide informed consent and agree to participate in the study.
• Exclusion Criteria:
• • • Those who need help reading through the participant information sheet, providing consent online, accessing experiment materials (chatbot or online leaflet), or answering surveys will be excluded. This may include people who do not have access to an online environment or people with severe cognitive impairments who cannot interact with the experiment materials. Also, those who have participated or are participating in similar studies regarding vaccination or experiments that utilize chatbots will be excluded.